Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid

被引：135

作者：

Anzano, MA

Peer, CW

Smith, JM

Mullen, LT

Shrader, MW

Logsdon, DL

Driver, CL

Brown, CC

Roberts, AB

Sporn, MB

机构：

[1] NCI,DIV CANC ETIOL,CHEMOPREVENT LAB,BETHESDA,MD 20892

[2] NCI,DIV CANC PREVENT & CONTROL,BIOMETRY BRANCH,BETHESDA,MD 20892

[3] SCI APPLICAT INT CORP,IN VIVO CARCINOGENESIS PROGRAM,FREDERICK,MD

[4] NCI,FREDERICK CANC RES & DEV CTR,FREDERICK,MD

[5] DARTMOUTH COLL SCH MED,HANOVER,NH

来源：

关键词：

D O I：

10.1093/jnci/88.2.123

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：123 / 125

页数：3

共 23 条

[1] [Anonymous], 1992, Lancet
[2] ANZANO MA, 1994, CANCER RES, V54, P4614
[3] ANZANO MA, 1994, CANCER RES, V54, P1653
[4] RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS
BLACK, LJ
SATO, M
ROWLEY, ER
MAGEE, DE
BEKELE, A
WILLIAMS, DC
CULLINAN, GJ
BENDELE, R
KAUFFMAN, RF
BENSCH, WR
FROLIK, CA
TERMINE, JD
BRYANT, HU
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 63 - 69
[5] ANTAGONISM OF ESTROGEN ACTION WITH A NEW BENZOTHIOPHENE DERIVED ANTI-ESTROGEN
BLACK, LJ
JONES, CD
FALCONE, JF
[J]. LIFE SCIENCES, 1983, 32 (09) : 1031 - 1036
[6] THE EFFECTS OF RALOXIFENE ON TIBIA HISTOMORPHOMETRY IN OVARIECTOMIZED RATS
EVANS, G
BRYANT, HU
MAGEE, D
SATO, M
TURNER, RT
[J]. ENDOCRINOLOGY, 1994, 134 (05) : 2283 - 2288
[7] GOTTARDIS MM, 1987, CANCER RES, V47, P4020
[8] GREAVES P, 1993, CANCER RES, V53, P3919
[9] HAN XL, 1992, CANCER RES, V52, P1360
[10] USE OF TAMOXIFEN FOR BREAST-CANCER - 28 YEARS LATER
JAIYESIMI, IA
BUZDAR, AU
DECKER, DA
HORTOBAGYI, GN
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) : 513 - 529